Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov;25(11):355-361.
doi: 10.1007/s11894-023-00892-7. Epub 2023 Aug 25.

Point-of-Care Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease

Affiliations
Review

Point-of-Care Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease

Michael Todd Dolinger et al. Curr Gastroenterol Rep. 2023 Nov.

Abstract

Purpose of review: Intestinal ultrasound (IUS) is an emerging non-invasive point-of-care tool utilized by pediatric gastroenterologists for accurately detecting and monitoring inflammatory bowel disease (IBD) activity. In this article, we reviewed the evidence supporting and technique to perform IUS for children with IBD.

Recent findings: IUS technique can visualize the colon from the distal sigmoid until the cecum and the terminal ileum without the need for bowel preparation, fasting, or sedation in children with IBD. IUS has been shown to be accurate to endoscopy in children with ulcerative colitis and Crohn's disease. IUS may be the most accurate biomarker to follow as a marker of treatment response that is predictive of endoscopic outcomes in children with IBD. Multiple studies have demonstrated that IUS can be performed at the point-of-care for IBD activity assessment in children. Recent studies have demonstrated the accuracy of IUS to endoscopy and magnetic resonance enterography with an ability to be repeated as a monitor of treatment response for tight control monitoring.

Keywords: Children; Cross-sectional imaging; Inflammatory bowel disease; Intestinal ultrasound.

PubMed Disclaimer

Similar articles

Cited by

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Torres J, et al. Crohn's disease. Lancet. 2017;389(10090):1741–1755.
    1. Krugliak Cleveland N, Torres J, Rubin DT. What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented? Gastroenterology. 2022;162:1396–408. - DOI - PubMed
    1. Conrad MA, Kelsen JR. The Treatment of Pediatric Inflammatory Bowel Disease with Biologic Therapies. Curr Gastroenterol Rep. 2020;22:36. - DOI - PubMed - PMC
    1. Turner D, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160:1570–83. - DOI - PubMed
    1. Dolinger MT. The role of noninvasive surrogates of inflammation in monitoring pediatric inflammatory bowel diseases: The old and the new. Gastroenterol Clin North Am. 2023;52(3):497–515.

LinkOut - more resources